Cargando…

Clinical update on the hybrid comprehensive stage II operation

OBJECTIVE: We previously described the hybrid comprehensive stage II operation as an alternate surgical procedure for a subset of patients with single ventricle congenital heart disease with adequate native ascending aortic outflow. Here we provide a clinical update on the 4 patients who have underg...

Descripción completa

Detalles Bibliográficos
Autores principales: Farias, Michael, Fleishman, Craig E., Nykanen, David, DeCampli, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390143/
https://www.ncbi.nlm.nih.gov/pubmed/36003736
http://dx.doi.org/10.1016/j.xjon.2021.04.019
_version_ 1784770587264024576
author Farias, Michael
Fleishman, Craig E.
Nykanen, David
DeCampli, William M.
author_facet Farias, Michael
Fleishman, Craig E.
Nykanen, David
DeCampli, William M.
author_sort Farias, Michael
collection PubMed
description OBJECTIVE: We previously described the hybrid comprehensive stage II operation as an alternate surgical procedure for a subset of patients with single ventricle congenital heart disease with adequate native ascending aortic outflow. Here we provide a clinical update on the 4 patients who have undergone this procedure. METHODS: After undergoing a hybrid approach to the stage I Norwood palliation, the hybrid comprehensive stage II procedure was performed with an incision to the main pulmonary artery (PA), dilation of the ductal stent, creation of a stented baffle between the branch PAs, and a bidirectional Glenn connection. With this approach, dissection of the distal arch and creation of a Damus-Kaye-Stansel anastomosis was avoided. A standard Fontan procedure was planned after the usual period of growth. RESULTS: The first patient, who had trisomy 21 and elevated PA pressures, died postoperatively due to left PA thrombosis. The subsequent 3 patients survived the procedure and remain clinically well. All have required catheterizations for reintervention on their stented intrapulmonary baffles and ductal arches, and all have undergone successful completion of their Fontan procedures. CONCLUSIONS: The hybrid comprehensive stage II is a feasible, less complex alternative to the conventional comprehensive stage II operation in a subset of patients with single ventricle physiology. Early postoperative anticoagulation therapy to avoid PA thrombosis is recommended, and restenting of the ductal arch is anticipated. Although the long-term consequences of separate outflow tracts supplying the upper and lower body is unknown, the 3 surviving patients with this circulation are doing well with their Fontan circulation at midterm follow-up.
format Online
Article
Text
id pubmed-9390143
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93901432022-08-23 Clinical update on the hybrid comprehensive stage II operation Farias, Michael Fleishman, Craig E. Nykanen, David DeCampli, William M. JTCVS Open Congenital: Hypoplastic Left Heart Syndrome OBJECTIVE: We previously described the hybrid comprehensive stage II operation as an alternate surgical procedure for a subset of patients with single ventricle congenital heart disease with adequate native ascending aortic outflow. Here we provide a clinical update on the 4 patients who have undergone this procedure. METHODS: After undergoing a hybrid approach to the stage I Norwood palliation, the hybrid comprehensive stage II procedure was performed with an incision to the main pulmonary artery (PA), dilation of the ductal stent, creation of a stented baffle between the branch PAs, and a bidirectional Glenn connection. With this approach, dissection of the distal arch and creation of a Damus-Kaye-Stansel anastomosis was avoided. A standard Fontan procedure was planned after the usual period of growth. RESULTS: The first patient, who had trisomy 21 and elevated PA pressures, died postoperatively due to left PA thrombosis. The subsequent 3 patients survived the procedure and remain clinically well. All have required catheterizations for reintervention on their stented intrapulmonary baffles and ductal arches, and all have undergone successful completion of their Fontan procedures. CONCLUSIONS: The hybrid comprehensive stage II is a feasible, less complex alternative to the conventional comprehensive stage II operation in a subset of patients with single ventricle physiology. Early postoperative anticoagulation therapy to avoid PA thrombosis is recommended, and restenting of the ductal arch is anticipated. Although the long-term consequences of separate outflow tracts supplying the upper and lower body is unknown, the 3 surviving patients with this circulation are doing well with their Fontan circulation at midterm follow-up. Elsevier 2021-05-08 /pmc/articles/PMC9390143/ /pubmed/36003736 http://dx.doi.org/10.1016/j.xjon.2021.04.019 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Congenital: Hypoplastic Left Heart Syndrome
Farias, Michael
Fleishman, Craig E.
Nykanen, David
DeCampli, William M.
Clinical update on the hybrid comprehensive stage II operation
title Clinical update on the hybrid comprehensive stage II operation
title_full Clinical update on the hybrid comprehensive stage II operation
title_fullStr Clinical update on the hybrid comprehensive stage II operation
title_full_unstemmed Clinical update on the hybrid comprehensive stage II operation
title_short Clinical update on the hybrid comprehensive stage II operation
title_sort clinical update on the hybrid comprehensive stage ii operation
topic Congenital: Hypoplastic Left Heart Syndrome
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390143/
https://www.ncbi.nlm.nih.gov/pubmed/36003736
http://dx.doi.org/10.1016/j.xjon.2021.04.019
work_keys_str_mv AT fariasmichael clinicalupdateonthehybridcomprehensivestageiioperation
AT fleishmancraige clinicalupdateonthehybridcomprehensivestageiioperation
AT nykanendavid clinicalupdateonthehybridcomprehensivestageiioperation
AT decampliwilliamm clinicalupdateonthehybridcomprehensivestageiioperation